SHYLICINE Trademark

Trademark Overview

On Thursday, March 21, 2019, a trademark application was filed for SHYLICINE with the United States Patent and Trademark Office. The USPTO has given the SHYLICINE trademark a serial number of 88350431. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by VANESSA RESEARCH, INC.. The SHYLICINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Microvillus Inclusion Disease (MVID)
shylicine

General Information

Serial Number88350431
Word MarkSHYLICINE
Filing DateThursday, March 21, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Microvillus Inclusion Disease (MVID)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVANESSA RESEARCH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamden, CT 06514
Party NameVANESSA RESEARCH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamden, CT 06514

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 20, 2022WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, September 20, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, March 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2022SOU EXTENSION 4 GRANTED
Wednesday, March 2, 2022SOU EXTENSION 4 FILED
Wednesday, March 2, 2022SOU TEAS EXTENSION RECEIVED
Saturday, September 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 2, 2021SOU EXTENSION 3 GRANTED
Thursday, September 2, 2021SOU EXTENSION 3 FILED
Thursday, September 2, 2021SOU TEAS EXTENSION RECEIVED
Monday, July 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021SOU EXTENSION 2 GRANTED
Tuesday, March 2, 2021SOU EXTENSION 2 FILED
Tuesday, March 2, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 1, 2020SOU EXTENSION 1 FILED
Tuesday, September 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 4, 2019ASSIGNED TO LIE
Friday, November 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 7, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, June 7, 2019PRIORITY ACTION E-MAILED
Friday, June 7, 2019PRIORITY ACTION WRITTEN
Friday, May 31, 2019ASSIGNED TO EXAMINER
Monday, April 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

shylicine disease mvid inclusion microvillus preparations treatment pharmaceutical